Cincor Pharma Inc (CINC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CINC | AMGN | VRTX | REGN | BMY |
| Company | Cincor Pharma Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 29.17 | 335.84 | 490.00 | 1,162.05 | 49.50 |
| High | 29.35 | 337.56 | 490.15 | 1,162.05 | 50.25 |
| Low | 29.02 | 332.92 | 483.95 | 1,152.01 | 49.26 |
| Last | 29.06 | 335.26 | 489.43 | 1,153.08 | 49.99 |
| Change | -0.14 | +2.81 | +4.06 | -0.27 | +0.86 |
| % Change | -0.48% | +0.85% | +0.84% | -0.02% | +1.75% |
| Volume | 6,349,700 | 2,360,500 | 695,500 | 346,800 | 11,823,300 |
| 20-Day Average Volume | 714,530 | 1,695,575 | 964,705 | 414,755 | 8,683,485 |
| Previous Close | 29.20 | 332.45 | 485.37 | 1,153.35 | 49.13 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 29.18 | 328.79 | 481.27 | 1,172.45 | 49.01 |
| 20-Day Raw Stochastic | 33.69% | 87.61% | 72.65% | 40.67% | 80.34% |
| 20-Day Relative Strength | 67.29% | 57.57% | 55.81% | 53.76% | 59.06% |
| Weighted Alpha | -35.90 | +26.73 | +38.03 | +41.62 | -8.77 |
| Today's Opinion | 40% Buy | 88% Buy | 72% Buy | 80% Buy | 56% Buy |
| Previous Opinion | 56% Buy | 88% Buy | 72% Buy | 80% Buy | 56% Buy |
| Last Month's Opinion | 24% Buy | 72% Buy | 56% Buy | 100% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.69% since 02/15/23 | +2.87% since 09/09/24 | +3.89% since 09/09/24 | +0.73% since 09/09/24 | +3.07% since 09/09/24 |
| Low | 28.94 on 02/22/23 | 320.30 on 09/11/24 | 460.69 on 09/11/24 | 1,113.24 on 09/11/24 | 47.76 on 09/12/24 |
| High | 29.62 on 02/17/23 | 337.56 on 09/16/24 | 490.15 on 09/16/24 | 1,170.58 on 09/13/24 | 50.25 on 09/16/24 |
| 1-Month | |||||
| %Chg | +0.80% since 01/23/23 | +4.30% since 08/16/24 | +2.53% since 08/16/24 | -2.22% since 08/16/24 | +1.28% since 08/16/24 |
| Low | 28.65 on 01/24/23 | 319.00 on 09/06/24 | 460.69 on 09/11/24 | 1,113.24 on 09/11/24 | 46.88 on 08/22/24 |
| High | 29.68 on 02/14/23 | 337.56 on 09/16/24 | 500.25 on 08/30/24 | 1,211.20 on 08/27/24 | 50.75 on 09/04/24 |
| 3-Month | |||||
| %Chg | +13.38% since 11/23/22 | +12.27% since 06/14/24 | +1.81% since 06/14/24 | +11.25% since 06/14/24 | +21.33% since 06/14/24 |
| Low | 10.53 on 12/19/22 | 296.56 on 06/17/24 | 458.04 on 08/13/24 | 1,011.67 on 07/03/24 | 39.35 on 07/05/24 |
| High | 29.68 on 02/14/23 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 1,211.20 on 08/27/24 | 51.19 on 07/29/24 |
| 6-Month | |||||
| %Chg | -17.49% since 08/23/22 | +24.69% since 03/15/24 | +20.05% since 03/15/24 | +19.56% since 03/15/24 | -4.49% since 03/15/24 |
| Low | 10.53 on 12/19/22 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.35 on 07/05/24 |
| High | 39.50 on 08/24/22 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 1,211.20 on 08/27/24 | 54.47 on 03/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,271,782 | 178,337,824 | 125,251,192 | 127,083,008 | 99,591,424 |
| Shares Outstanding, K | 43,764 | 536,435 | 258,053 | 110,186 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -50,370,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,388,000,000 | 2,645,600,000 | 3,547,100,000 | 12,201,000,000 |
| Last Quarter Net Income | -20,977,559 | 746,000,000 | -3,593,600,000 | 1,432,300,000 | 1,680,000,000 |
| 60-Month Beta | N/A | 0.61 | 0.40 | 0.12 | 0.46 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.51 on 11/03/22 | 4.97 on 08/06/24 | -12.83 on 08/01/24 | 11.56 on 08/01/24 | 2.07 on 07/26/24 |
| Latest Earnings Date | 03/28/23 | 10/29/24 | 11/04/24 | 11/07/24 | 10/31/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | N/A | 0.600 on 07/05/24 |
| Next Ex-Dividends Date | N/A | 08/16/24 | N/A | N/A | 10/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.75 | 0.00 | 30.31 | 35.21 |